Stay updated on Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.

Latest updates to the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page
- Check3 days agoChange DetectedNew version entries have been added to the Record History, updating the list with recent submission dates and changes to sections such as Study Status and Contacts/Locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference8%

- Check39 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page has been updated to v3.0.2 from v3.0.1. No substantive core content changes are detected, and the 'Back to Top' link was removed.SummaryDifference0.5%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%

- Check67 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference79%

Stay in the know with updates to Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.